Cargando…
Q fever vaccine development: Challenges and progress in balancing safety and efficacy
The existing human vaccine against Q fever, a zoonotic disease of biothreat concern, is approved only in Australia. In this issue of Cell Reports Medicine, Gregory and colleagues describe a new vaccine candidate that overcomes specific concerns hindering wider acceptance of the commercial vaccine.(1...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715067/ https://www.ncbi.nlm.nih.gov/pubmed/35028619 http://dx.doi.org/10.1016/j.xcrm.2021.100480 |